AU655507B2 - Syringe - Google Patents

Syringe Download PDF

Info

Publication number
AU655507B2
AU655507B2 AU27118/92A AU2711892A AU655507B2 AU 655507 B2 AU655507 B2 AU 655507B2 AU 27118/92 A AU27118/92 A AU 27118/92A AU 2711892 A AU2711892 A AU 2711892A AU 655507 B2 AU655507 B2 AU 655507B2
Authority
AU
Australia
Prior art keywords
plunger
syringe
needle
needle holder
flange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27118/92A
Other versions
AU2711892A (en
Inventor
Darryl Gordon Robb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robb Pascal Patent Pty Ltd
Original Assignee
Robb Pascal Patent Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robb Pascal Patent Pty Ltd filed Critical Robb Pascal Patent Pty Ltd
Priority to AU27118/92A priority Critical patent/AU655507B2/en
Publication of AU2711892A publication Critical patent/AU2711892A/en
Application granted granted Critical
Publication of AU655507B2 publication Critical patent/AU655507B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

-1I- 5550 7
AUSTRALIA
Patents Act 1990 ROBB PASCAL PATENT PTY LTD
ORIGINAL
COMPLETE SPECIFCATION STANDARD) PATENT 9@ 4*S* S S
S~
S S *0
S
S
'C.
U. C Invention Title: Syringe The following statement is a full description of this invention including the best method of performing it known to us:r 4 2 Field of the Invention The present invention relates to a syringe, and more particularly to a safety syringe for preventing contamination, fear of contamination and physical injury by "needle stick" by the syringe needle after use and/or for preventing reuse of the syringe.
Background Art In order to minimise the risk of contamination from a used syringe, it is common practice for used syringes to be deposited into heavy duty plastic bins which cannot be pierced by the needles. The bin and contents are then moved to a disposal facility at which they are incinerated. This means of disposal is of limited effect as it does not eliminate "needle stick" risk between needle use and disposal. Current disposal methods are also relatively expensive.
Numerous attempts have been made to design an acceptable syringe in which, after use, the needle is withdrawn into the body of the syringe and retained there in some manner. These designs are all directed to the same end of covering the needle after use to prevent inadvertent "needle stick" injuries with their attendant risk of cross-infection and to prevent reuse of the syringe. In many of these prior art arrangements the 25 withdrawal of the needle into the body is entirely manual *0o o* *0 °and requires the syringe user to remember to make some deliberate relative movement, normally between the plunger
**OQ
and the body, to effect withdrawal of the needle into the body of the syringe. Proposals have been made, as in 30 Australian Patent Specifications 593,513, 594,634 and o 35,676/89, to induce automatic withdrawal of the plunger o into the body by the use of a helically coiled spring.
This necessitates the use of additional and costly parts in the syringe and complicates its assembly. In its first aspect the present invention is directed to an alternative 1I 14- 3 arrangement for the automatic withdrawal of a syringe needle into the body of the syringe.
In the above proposals for automatic withdrawal of the plunger they have the disadvantage that immediately the positive manual pressure holding the plunger in a depressed condition is removed the spring will immediately commence the return of the plunger to its extended condition and simultaneously commence withdrawal of the needle into the body of the syringe. This could cause tissue tear and inadvertent and unwanted suction of blood into the syringe unless the operator consciously keeps the plunger depressed until the syringe is fully withdrawn from the patient's body. In a second aspect the present invention provides braking means to slow at least the initial rate of withdrawal of the needle into the body of the syringe.
Disclosure of the Invention there is provided a syringe comprising a body, a plunr 20 mounted within the body, means for connecting the unger to a needle holder at the end of an injection oke of the plunger whereby subsequent retraction o he plunger withdraws the needle into a shielded pos ion within the body, and energy storage means energ' ble by the insertion stroke to cause such wi rawal of the plunger and needle after the injection roke, resilient braking means being disposed within e space defined between the Sbody and the plunger, a eing disposed on one of them and bearing against other sufficiently to retard but c, 30 not stop the with awal of the plunger and needle after the injection aroke.
In a ferred embodiment of the first aspect of the inventi the resilient braking means is formed integrally with ealing means defining one end of a vacuum chamber -ling piton 4: L -4storage means. It is to be understood, however, at the resilient braking means could be applied to a s inge in which the energy storage means is other than /vacuum chamber.
It is preferred that the resilient br ing means is moveable longitudinally of that one of t body and the plunger to which it is affixed so as t alter the braking force it applies to the other of thoS members. This allows the withdrawal of the plunge under the action of the vacuum chamber to be prevente. until the completion of injection stroke of the plunger /f desired.
In a second aspect the p sent invention consists in a syringe comprising a body a plunger mounted within the body, means for connectin the plunger to a needle holder at the end of an injecti n stroke of the plunger whereby subsequent retraction the plunger withdraws the needle into a shielded posi on within the body, stop means attached to the bod or to the plunger to prevent depression of th /plunger into the body sufficient to .connect the pl ger to the needle holder in a first stroke of the plunge into the body, engagement means on the other one o the body or the plunger to engage the stop means upo completion of the first stroke of the plunger 25 and to l.nder the stop member inoperative upon a first retra ion of the plunger to draw an injectable liquid intt the syringe following the first stroke such that the p nger may be connected to the needle holder on -First 30 According to abtt~a aspect of the present invention i there is provided a syringe comprising a body, a plunger mounted within the body, a needle holder releasably retained in one end of the syringe body and connection means for connecting the plunger to the needle holder at the end of an injection stroke of the plunger whereby J NsI TI \*k subsequent retraction of the plunger withdraws the needle into a shielded position within the body, the syringe being characterised in that the needle holder includes a radially extending flange adapted to releasably engage with complementary engagement means within the body, the flange also surrounds and partially overlies an undercut recess in the needle holder, the connection means comprising a protuberance on the plunger which is adapted to engage with a radially inner portion of the flange and to move it into the undercut recess on the needle holder and thereby draw a radially outer portion of the flange radially inwardly free from the complementary engagement means.
In one embodiment the body of the syringe has a forward end, a rearward end, and a bore extending from the forward end to the rearward end, the needle holder being releasably retained on the body proximate the forward end r*r and the plunger having an end mounted slidably within the bore of the body and extending out of the rearward end of the body.
In another embodiment the syringe further includes resilient braking means for retarding the retraction of the plunger. The resilient braking means is preferably i disposed within a space between the bore and the plunger and is either disposed on the body and bearing on the plunger or is disposed on the plunger and bears on the body thereby providing a braking force sufficient to retard but not stop the retraction of the plunger. The braking means preferably comprises a resilient cylindrical member disposed within the body and having engagement members resiliently bearing against the plunger, the cylindrical member being removable longitudinally along the body between zones of different internal diameter to alter the braking force it applies to the plunger.
iA j r ;-i 7 l 5a In another embodiment the syringe further includes stop means provided on the syringe body to prevent complete depression of the plunger into the body until after the syringe has been filled with an injectable liquid. The stop means preferably comprises an abutment formed on the body of the syringe which is engagable by engagement means on the plunger when the plunger is first depressed. The abutment means is preferably sheared from the body by a subsequent retraction of the plunger.
In another embodiment of the invention the body preferably includes a plurality of pivotable fingers within the bore proximate the forwlrd end of the body, the plurality of pivotal fingers pivoting radially inwards so as to form an iris to substantially occlude the one end of 15 the body when the needle on the needle holder is drawn into the body.
In another embodiment of the invention the needle is preferably disposed on the needle holder at an angle to a longitudinal axis of the body.
20 Brief Description of the Drawings Preferred and alternative embodiments of the invention will now be further described with reference to the accompanying drawings in which; ~Fig. 1 is a schematic longitudinal section of a 25 syringe in accordance with the preferred embodiment of the invention, the upper half of the section showing the syringe in a condition prior to use and the lower half of the section showing the syringe in a condition at the end of its injection stroke, the lower half of the section also showing an alternative mounting for the syringe needle; 4 Fig. 2 shows five longitudinal sectional views through a syringe according to another embodiment of the present invention; Fig. 2a shows the syringe in the condition in which it is shipped for use; Fig. 2b shows
I
Gj 'Ah T: 5b the syringe in a condition ready to draw up an injectable liquid; Fig. 2c shows the syringe in a condition in which the liquid has been drawn up and the dose of the liquid is about to be selected with an accompanying exclusion of air from the syringe; Fig. 2d shows the syringe in a condition immediately after the injection has been given; and Fig. 2e shows the syringe in a condition after the needle has been automatically withdrawn into the syringe body; t t rc
I
i Ir t CC C" -i c cc c 6 Fig. 3 is a longitudinal sectional view through one end of a narrow base syringe according to another embodiment of this invention; Fig. 4 is a longitudinal sectional view through needle holder and adjacent end of the body of a wide base syringe according to another embodiment of the present invention; and Fig. 5 shows five longitudinal sectional views through a syringe according to another embodiment of the present invention; Fig. 5a shows the syringe in the condition in which it is shipped for use; Fig. 5b shows the syringe in a condition ready to draw up an injectable liquid; Fig. 5c shows the syringe in a condition in which the liquid has been drawn up and the dose of the liquid is about to be selected with an accompanying exclusion of air from the syringe; 2 Fig. 5d shows the syringe in a condition immediately after the injection has been give; and Fig. 5e shows the syringe in a condition after the needle holder and needle have been automatically withdrawn into the syringe body.
BEST METHOD-FOR CARRYING OUT THE INVENTION o" 25 The syringe shown in Fig. 1 comprises a body 2 and a plunger 4 mounted within the body 2. A needle holder 6 is mounted at the forward or inner end of the body 2 by means i of an annular array of releasable locking pawls 8 which normally engage over a shoulder 10 of the holder 6 in order to prevent retraction of the holder 6 into the body 2. A forwardly-projecting part 12 of the needle holder 6 is of conventional form in order to mount a standard needle which is a friction fit on the holder.
Alternatively the body 2 can mount a needle with an integral holder 6b as shown in the lower part of Fig. 1, Si: -7the holder 6b co-operating with the releasable pawls 8 in the same manner as the holder 6. The pawls 8 extend rearwardly from a sleeve 13 which centres the needle holder in the body 2.
The plunger 4 carries, towards its forward end, an annular travelling seal 14 in sliding contact with the inner surface of the syringe body 2. The seal 14 is intended to form a high quality hermetic seal and is shaped to define a series of axially spaced annular sealing zones against the body 2. A similar high quality annular seal 16 is fixedly mounted on the body 2 towards its rear or outer end. This fixed seal 16 has on its inner surface a series of annular sealing zones which seal against the outer surface of the plunger 4. The space 18 defined between the two seals 14, 16 constitutes a vacuum chamber. Upon actuation of the syringe the movement of the seal 14 away from the seal 16 generates a vacuum in the vacuum chamber 18 to cause eventual withdrawal of the S• holder 6 or 6b together with the needle into the syringe 20 body 2 after use.
The forward end of the plunger 4 includes a radiallyextending braking flange 20 which frictionally engages the inner surface of the body 2 in order to prevent nonintentional retraction of the plunger 4 under the o 25 influence of the vacuum created in the vacuum chamber 18.
The braking flange 20 is a resilient flange defined at an outer edge of a conical wedge 22 formed at the forward end .of the plunger. The conical wedge 22 is adapted to co-operate with the retaining pawls 8 for the needle holder in order to release the pawls 8 as will subsequently be described. The forward end of the plunger is also formed with an annular array of flexible pawls 24 arranged inwardly of the conical wedge 22. The pawls 24 are shaped to engage into an undercut groove 26 formed in I the head of the needle holder in order to anchor the !i 8 needle holder to the plunger 4 when the plunger 4 is in its forward position.
A removable stop ring 28 is mounted in an inner annular seat formed in the inner surface of the body 2 rearwardly of the fixed seal 16. The stop ring 28 is a split ring which is resiliently biased to an external diameter greater than that of the inner seat. An outer seat 30 for the stop ring 28 is formed in the body 2 rearwardly of the inner seat. The stop ring 28 has, on its internal surface, an annular groove 32 adapted to receive an annular rim 34 formed on the external surface of the plunger 4 towards the rear end of the plunger.
The syringe is supplied with the plunger 4 in its retracted position. In order to use the syringe, the plunger 4 is pushed inwardly to expel most of the air from the fluid-receiving chamber which is defined between the forward end of the plunger 4 and the needle holder 6 or 6b.
**Insertion of the plunger during this phase is limited o by the stop ring 28, the rear edge of which engages a ooaoo 20 shoulder 36 at the outer end of the plunger 4. In this limit position, the annular groove 32 in the stop ring 28 °is axially aligned with, and is engaged by, the projcting annular rim 34 on the plunger body whereby the stop 2 ring 28 is releasably connected to the plunger 4. The *o 25 stop ring 28 prevents insertion of the plunger 4 to its forwardmost position and hence prevents connection of the pawls 24 at the forward end of the plunger 4 with the groove 26 in the head of the needle holder. The plunger 4 booe "can then be retracted to draw fluid into the fluid chamber 30 of the syringe. It is to be noted that during this mode, :the braking flange 20 on the plunger frictionally engages the inner wall of the body 2 in order to prevent retraction of the plunger under the influence of the vacuum generated within the vacuum chamber 18 during the insertion of the plunger. As mentioned above, at the end i~ I
UI
I
-9of the initial insertion stroke, the stop ring 28 was engaged by, and was connected to, the plunger. As the plunger is withdrawn to draw fluid into the chamber, the stop ring 28 is withdrawn with the plunger until the stop ring 28 is clear of the inner seat. When the stop ring moves into alignment with the outer seat 30, the inherent resilience of the stop ring 28 enables the stop ring to expand into the outer seat 30. The increased diameter of the outer seat 30 enables the stop ring 28 to expand to such a diameter that it disengages from the annular rim 34 on the plunger and is retained in the outer seat, as shown in the lower half of Fig. A retaining lip 37 at the outer end of the outer seat 30 ensures that the ring 28 is retained within the seat in order to prevent accidental displacement of the ring 28 and possible jamming of the plunger.
When the required quantity of fluid has been drawn into the fluid chamber, the plunger is then depressed in order to expel air from the chamber in the usual manner 20 and then to discharge the fluid into the patient. It is to be noted that as the plunger reaches the end of its o e" injection stroke, the plunger is no longer subject to the influence of the stop ring 28 which is now in its larger diameter outer seat 30 and this enables the plunger to be moved into its fully forwards condition for discharge of substantially the entire contents of the fluid chamber.
During the injection stroke, vacuum again builds up in the iBe o~o vacuum chamber 18, the effect of this vacuum being resisted by the braking flange 20 which frictionally 30 engages the inner surface of the syringe body.
As the plunger nears the end of its injection stroke, that is beyond the stop position previously defined by the r presence of the stop ring 28 when in its inner seat, the conical wedge 22 contacts the retaining pawls 8 in order i to deflect these pawls outwardly beyond the retaining
I!
4il Sii r 9
TI
10 shoulder 10 on the needle holder and into engagement with the inner surface of the syringe body as shown in the lower half of Fig. 1. At the same time, the pawls 24 at the plunger move into snap-engagement in the undercut groove 26 in the head of the needle holder in order to connect the needle holder with the plunger. The rear ends 8a of the retaining pawls 8 constitute shear knives which, when the pawls 8 are deflected outwardly by the wedge 22, lie against the inner surface of the syringe body in order to contact the braking flange 20 and to deflect the flange 20 inwardly and rearwardly by plastic deformation of the flange, thereby reducing or removing the frictional contact between the braking flange 20 and the syringe body. When manual pressure is removed from the rear end of the plunger and with the braking action of the braking flange 20 removed or reduced consequent on its plastic deformation, the vacuum generated in the vacuum chamber 18 during the injection stroke acts to withdraw •the plunger and thus the needle holder and needle which is now attached to the plunger. In the withdrawn position of the plunger, the needle is enclosed fully within the plunger body with no portion of the needle exposed for accidental contact. The needle holder is a relatively loose fit on the pawls 24 so that the axis of the needae holder and needle can incline relative to the syringe body whereby the tip of the needle will lie to one side of the syringe body and will be prevented by the sleeve 13 from accidental extension from the body. The sleeve 13 may also comprise a central iris structure held open by the S 30 needle holder when in its operative position. As soon as the needle holder is withdrawn by the plunger, the iris structure contracts or closes in order to close the central aperture of the sleeve 13 and thereby to prevent any access to the interior of the syringe body.
As no part of the needle is exposed after use of the ~i:!i SStatus: F.B. RICE CO. PATENT
ATTORNEYS
I
11 syringe, the syringe can be disposed of in a conventional plastic bag. The absence of exposure of the needle also assists in preventing the spread of infection by contaminated needles.
The syringe shown in Figs. 2a to 2e comprises a body 100 and a plunger 101. A needle holder 102 is mounted at the forward or inner end of the body 100. The needle holder 102 has at its forward end a cylindrical boss 103 inclined slightly to the longitudinal axis of the syringe body 100. A needle 104 is disposed on the boss 103 and is held in place thereon by a conventional U-lock fitting 105. Due to the inclination of the boss 103 the needle 104 is also inclined to the longitudinal axis of the body 100. The needle holder 102 has a bore 106 extending longitudinally through it and communicating at one end with an undercut recess 107, adapted to engage with a suitably shaped protuberance on 4* *the plunger as will be hereinafter described, and at the other end with the needle 104. A flange 108 on the needle 20 holder 102 surrounding the undercut recess 107 engages "behind an annular rib 109 on the inside wall of the body 100. A plurality of triangular sprags 111 project inwardly from the forward end of the body 100 and engage about the circumference of the needle holder 102. The engagement of the flange 108 of the needle holder 102 with the annular rib 109 of the body 100 and the engagement of the sprags 111 about the circumference of the needle holder 102 serve to securely locate the needle holder at the forward end of the body 100 until it is released therefrom by engagement with the plunger as will be hereinafter described.
S' r The body 100 defines a substantially cylindrical bore 110 extending from the annular rib 109 which retains the needle holder 102 in place at the forward end of the body 100 to a second annular rib 113. Rearwardly of the 12 annular rib 113 the body 100 increases in internal diameter through a frusto-conical zone 114 to a substantially cylindrical zone 115. The cylindrical zone 115 is directly connected to a second cylindrical zone 116 of slightly increased internal diameter which in turn is connected to a tapering zone 117 which tapers outwardly in diameter to the free end 119 of the body 100. Between the zones 116 and 117 the body is formed integrally with an annular collar 118. This collar 118 is moulded extending rearwardly of the junction between the two zones 116 and 117 and is then turned over to lie within zone 116, forming an inwardly directed annular abutment. The free end 110 of the body 100 is moulded integrally with a pair of diametrically opposed stop members 121 joined by a thin flexible ring 122. The stop members 121 and ring 122 are also moulded integrally with, and extended rearwardly of, the body 100 and are C tVCE then turned over to lie within the zone 117.
A resilient a,nular braking and sealing member 123 is positioned within the zones 115 and 116 of the body 100.
The member 123 includes a pair of inwardly directed annular sealing lips 124 sliding radially inwardly from the member 123 and adapted to sealingly engage about the plunger 101. Rearwardly of the lips are three braking t 25 ribs 125, which could in another embodiment of the invention be replaced by rows of bosses which may serve the same purpose. The braking ribs are adapted to apply a i braking force to the plunger 101. The radially outer C. c, surface of the member 123 carries at its forward end a circumferential rib 126. In the initial configuration of the syringe the member 123 is positioned with the rib 126 abutting against the forward end of the collar 118. The collar 118 then surrounds the member 123 and serves to compress the braking ribs 125 against the plunger 101.
The rearward end of the syringe body 100 is formed 13 with a pair of outwardly extending finger grips 112 disposed in diametric opposition about the body 100.
The plunger 101 includes an elongate shaft 127 and at its forward end a radially extending sealing flange 128 in sealing engagement with the bore 110 of the body 100. At its forward free end the plunger 101 is formed with a protuberance 129 adapted to engage with the recess 107 in the needle holder 102. The protuberance 129 and recess 107 are so dimensioned that on engagement of the protuberance 129 in the recess 107 an inwardly directed flange 131 will be pivoted inwardly and forwardly by contact with the protuberance 129 which will cause the flange 108 on the needle holder to be pivoted rearwardly and inwardly to free the flange 108 from the annular 15 rib 109 on the bore of the body 100.
The rearward end of the plunger 101 is forced with an enlarged head 132 which head 132 includes at its forward end a radially outwardly extending flange 133. The enlarged head 132 on the plunger 101 is preferably formed by heat reforming the rearward end of the plunger after the sealing and braking member 123 has been positioned on the stem 127 of the plunger 101.
~In use the syringe is shipped in conditions depicted in Fig. 2a. The plunger 101 is in its fully retracted position and the braking and sealing member 123 is surrounded by the collar 118 such that the braking ribs 125 are urged firmly against the shaft 127 of the p plunger 101.
In order to draw an injectable fluid into the syringe the plunger 101 is depressed to the position shown in Fig. 2b. The plunger 101 is depressed until it is stopped by the engagement of the flange 133 on the head 132 of the i plunger 101 with a pair of inwardly directed recesses 134 in opposed faces of the stop members 121. This engagement occurs when the protuberance 129 on the forward end of the ;i
'I
L.iI 14 plunger 101 is closely adjacent but not engaged with the undercut recess 107 in the needle holder 102. Subsequent retraction of the plunger 101 will draw an injectable liquid, into which the needle has been inserted, into the body 100 of the syringe. Such retraction will also shear the thin connection between the stop members 121 and the body 100 of the syringe. The dose of liquid in the syringe may then be adjusted, and air removed from the syringe, by depression of the plunger 101. The braking force applied to the shaft 127 of the plunger 101 is at this point sufficient to resist movement of the plunger 101 relative to the body 100 under the influence of the vacuum created between the braking and sealing member 123 and the sealing flange 128 as the plunger 101 is depressed into the body 100. Thus movement of the plunger 101 relative to the body 100 will only occur by manual application of force to the plunger 101 by the person using the syringe.
i When an injection is to be given the needle is inserted into the patient in a conventional manner. This insertion is facilitated by the inclination of the needle 104 relative to the body 100 of the syringe as the body 100 is disposed at a more convenient angle to the skin of the patient, at least in the case of intravenous 25 injections, than would be the case if the needle 104 was in axial alignment with the body 100 of the syringe. The plunger 101 is then depressed to inject the liquid into the patient. At the end of the plunger stroke the protuberance 129 will engage with the undercut recess 107 of the needle holder 102, as the earlier removal of the stop members 121 now allows the plunger 101 to be fully depressed. The engagement of the protuberance 129 with the undercut recess 107 causes the flange 108 on the needle holder 102 to be drawn radially inwardly free of the circumferential groove 109 in the body 100. As the
I
15 protuberance 129 is entering the undercut recess 107 so the flange 133 on the head of the plunger 101 engages the rearward end of the braking and sealing member 123 pushing it into zone 115 of the syringe body 100 free of collar 118. The braking and sealing member 123 can expand radially within the zone 115 so that the braking pressure on the shaft 127 of the plunger 101 is reduced. When the syringe is withdrawn from the patient the vacuum created between the braking and sealing member 123 and the sealing flange 108 will be sufficient to slowly draw the plunger 101 back into the body 100 of the syringe. The plunger 101 will also draw the needle holder 102, now freed from engagement with the body 100, and the needle 104 into the body. As the needle holder 102 is 15 drawn into the body the free ends of the triangular sprags 111 will spring radially inwardly to form an iris precluding egress of the needle 104 outwardly from the now open forward end of the syringe body 100.
SThe vacuum pressure created in the syringe body 100 will be sufficient to draw the needle 104 fully into the body 100 behind the iris formed by the triangular sprags 111, and to engage radially outwardly directed fingers 135 on the shaft 127 of the plunger 101 behind at least the forwardmost one of sealing lips 124. Any S subsequent use of the syringe is prevented firstly by the fact that the needle 104 is trapped within the body 101 by the sprags 111 and the inclination of the needle 104 and secondly by the fact that any depression of the .plunger 101 will cause fingers 135 to drag the braking and sealing member 123 into the frusto-conical zone 114 of the i body where the braking ribs 125 of the braking and sealing I member 123 will be caused to tightly bind against the j shaft 127 of the plunger 101. i 1 The arrangement of Fig. 3 shows the application of the present invention to a narrow bore syringe which would facttha theneele 14 i~trapedwithn te boy 11 P 16 typically be used for giving an injection of about iml of liquid to a patient. In this case the construction and operation of the syringe is as has been described with reference to Figs. 2a to 2e except that the vacuum pressure is created between the braking and sealing member 123 and an additional sealing flange 136 mounted on the shaft 127 of the plunger 101 intermediate its ends.
A step 137 on the shaft 127 causes the sealing flange 136 to move downwardly of the bore 110 as the plunger is depressed creating a vacuum between the sealing lips 124 and the flange 136. This vacuum will draw the flange 136 rearwardly when the injection has been completed and the flange 136 will carry the plunger 101 and the needle 104 rearwardly with it.
The arrangement of Fig. 4 shows the needle holder 102 positioned in a wide bore syringe. In this case the arrangement is as described with reference to Figs. 2a to 2e except that the sprags 111 dc not need to be moulded 0. so as to spring inwardly to form an iris upon withdrawal of the needle holder into the body 100 as the inturned flanges 13R and 138 are sufficient to prevent the Sneedle 104 from being re-extended from the syringe once it has been drawn into the body 100.
The syringe shown in Figs. 5a to 5e is generally 25 similar to that described with reference to Figs. 2a to 2e comprise a syringe body 200 and a plunger 201. A needle holder 202 is mounted at a forward end of the syringe body 200. The needle holder 202 has a body 206 which is generally cylindrical in shape and which has at its forward end a tapering tubular boss 203 coaxial with the syringe body 200. A needle (not shown) may be disposed on the boss 203 and be held in place by friction fit with the tapering boss 203. The needle holder 202 has a bore 204 extending through it and communicating at its rear end with an undercut recess 205, which is adapted to 1w s 1 17 engage with a suitably shaped protuberance on the plunger 201 as will be hereinafter described. A cylindrical flange 207 extends coaxially with the syringe body 200 from the end of the body 206 adjacent the boss 203. This flange 207 is provided on its free edge with teeth 208. The body 206 of the needle holder 202 is formed at its other end with an outwardly directed annular flange 209 which is adapted to engage behind an inwardly directed annular rib 210 on the inside surface of the syringe body 200. The body 206 of the needle holder reduces in diameter slightly between the flange 207 and 209 at its respective ends such that adjacent the undercut recess there is a slight clearance between the radially outer surface of the needle holder 202 and the inside surface of the syringe body 200. The undercut recess 205 is bounded on its inner side by an overhanging, inwardly directed annular lip 211.
The engagement of the flange 209 of the needle holder 202 behind the annular rib 210 on the inside surface of the syringe body 200 serves to securely locate the needle holder 202 at the forward end of the syringe body 200 until it is released therefrom by engagement with the plunger as will be hereinafter described. The teeth 208 on the needle holder 202 interdigitate with corresponding teeth 212 on an inwardly directed flange 213' at the forward end of the syringe body 200. This interdigitation prevents rotation of the needle holder 202 i j I relative to the syringe body 200 when the needle I ter: holder 202 is secured in place in the forward end of the syringe body 200. The syringe body 200 defines a substantially cylindrical bore 214 extending from the annular rib 210 to a radially outwardly expanding frusto-conical section of bore 215 and a cylindrical section 216 of expanded i diameter adjacent the rear end of the syringe body 200. A 1_ 18 pair of finger engaging tabs 217 extend from diametrically opposed sides of the rear end of the syringe body 200.
The plunger 201 includes an elongate shaft 218. At its forward end it has an axially extending I 5 protuberance 219 formed with a series of circumferential serrations 221. Behind the protuberance 219 is a frusto-conical boss 222 coaxial with the plunger 201 and tapering inwardly towards its forward end. Behind the boss 222 are a pair of spaced apart annular enlargements 223 and 224 of the diameter of the shaft 218 of the plunger 201. A cylindrical piston 225 formed of a resilient rubber or plastics material is positioned about the plunger 201 between the boss 222 and the enlargement 224. The piston 225 is held against axial the enlargements 223 and 224. Rearwardly of the enlargement the plunger 201 is formed with a pair of prongs 226 positioned on diametrically opposite sides of the plunger 201.
The rear end of the plunger 201 is formed integrally with a circular head 227 lying in a plane normal to the axis of the shaft 218 of the plunger 201. The head 227 is Sjoined to the shaft 218 by four ribs 228 spaced evenly around the circumference of the shaft 218. A diametrically opposed pair of these ribs 228 carry legs 229. Each leg 229 is formed with a bifurcated free end 231. Each leg 229 is initially (as seen in Fig. joined to its corresponding rib 228 adjacent the head 227 Sand extends forwardly lying in the plane of that rib which passes through the axis of the plunger 201. Each leg 229 is spaced slightly radially outwardly of its corresponding rib 228 and it extends slightly radially inwardly towards the axis of the plunger 201 to an elbow 232 and then extends slightly radially outwardly to the end 231.
An integral rear seal and braking member 233 is I i Q
I
191 19 positioned within the enlarged cylindrical portion 216 of the syringe body 200. This member 233 has an annular body 234 formed of a resilient rubber or plastics material.
and a bore 235 coaxial with the syringe body 200. At its rear end the annular body 234 has a radially outwardly extending annular flange 236 bearing against the inside of the bore 216 and a radially inwardly extending wiping flange 237 which bears against the shaft 218 of the plunger 201. Forwardly of flange 236 there is an annular recess 238 and then a further annular flange 239 and a further portion 241 of reduced external diameter. Down the bore 235 of the annular body 234 there is forwardly of the flange 237 a plurality of annular braking rib 242, then a plurality of sealing ribs 243 and then, radially inside the portion 241 of reduced external diameter, is a portion 244 of increased internal diameter which terminates at its forward end in a rearwardly projecting annular lip 245. There are a number of spaced apart abutments 240 disposed about the inside surface of the syringe body 200 at the level of the braking ribs 242.
These abutments serve to urge the braking ribs 242 firmly against the shaft 218 of the plunger 201 when the rear seal and braking member 233 is in the position shown in Fig. S 25 In use the syringe is initially in the condition shown in Fig. 5a. When the plunger 201 is depressed the piston 225 slides down the bore 214 of the syringe body 200 until the bifurcated ends 231 of the legs 229 engage with the rearward free edge of the portion 216 of the syringe body 200. This engagement prevents connection of the protuberance 219 with the bore 204 of the needle holder 202. Pressure on the head 227 of the plunger 201 causes a deformation of the legs 229 at their point of connection with the ribs 218 and at their elbows 232 as is seen in Fig. 5b. The memory characteristics of the 1 1 n
K
2_
I:
20 a a a *aar~a plastic from which plunger 201 is formed is such that when the plunger 201 is manually retracted from the position shown in Fig. 5b to that shown in Fig. 5c the legs 229 spring outwardly so that upon the plunger 201 again being depressed the bifurcated ends of the legs will no longer contact the free end of the syringe body 200 and the plunger will be able to be fully depressed into syringe body 200 as is shown in Fig. The initial retraction of the plunger 201 must be done manually, not withstanding the creation of a vacuum between the piston 225 and the rear seal and braking member 233, due to the engagement of braking rib 242 against the shaft 218 of the plunger 201. This manual retraction, from the position shown in Fig. 5b to that 15 shown in Fig. 5c, is used to draw a liquid to be injected into the syringe body. After adjustment of the volume of the liquid in the syringe in the usual way the needle (not shown) is inserted into the patient and the plunger 201 depressed.
As the injection stroke of the plunger 201 is completed the plunger moves into the position shown in Fig. 5d. The protuberance 219 enters the bore 204 of the needle holder and the annular ribs 221 thereon frictionally engage with the needle holder 202. At the same time the frusto-conical boss 222 engages with the inwardly directed flange 211 cantilevering it forwardly and radially outwardly into the undercut recess 205, this draws the flange 209 radially inwardly. This effect is further enhanced by the frusto-conical shape of the boss 222 which acts as a wedge to further force flange 211 radially outwardly.
As the protuberance 219 is engaging with the needle holder 202 so the ribs 228 at the head end of the plunger 201 are engaging with the rear end of the rear seal and braking member 233 and forcing it forwardly along 1 -21 the cylindrical section 216 of the syringe body 200. The portion 241 of the member 233 will engage with the frusto-conical section 214 of the syringe body 200 and be compressed radially inwardly by it forcing the lip 245 radially inwardly towards the shaft 218.
As the rear seal and braking member is forced forwardly it slides off the abutments 240. This allows the braking ribs 42 to expand radially outwardly thereby reducing the braking force applied to the shaft 218. The reduction of the braking force exerted by the braking ribs 243 means that the vacuum generated between the rear seal and braking member 233 and the piston 225 is sufficient to now withdraw the plunger into the syringe body when the user's injection pressure is removed from the head 227 of the plunger 201.
The vacuum force withdrawing the plunger 201 also withdraws the needle holder 202 as the protuberance 219 on the plunger 201 is engaged with the bore 204 of the needle holder 202 and the flange 209 has been drawn radially inwardly sufficiently to clear the rib 210 with which flange 209 would normally engaged. When the plunger 202 S: is fully retracted by the vacuum force the prongs 226 engage behind the radially inwardly directed flange 245 on the rear seal and braking member 233. This engagement prevents the plunger 201 from again being depressed and traps a needle disposed on the needle holder within the
CCC..
syringe body 200.
The embodiments of the invention are given for the purpose of example only and are not intended to limit the broad scope of the present invention as defined by the claims. The needle holder 102 could if desired be held in place in the body 100 of the syringe by a friction fit without the need for the rib 109. Similarly the braking ribs 125 could be replaced by other configuration of means i adapted to apply a braking effect between the plunger 101 and the syringe body 100.
I

Claims (8)

1. A syringe comprising a body, a plunger mounted within the body, a needle holder releasably retained in one end of the syringe body and connection means for connecting the plunger to the needle holder at the end of an injection stroke of the plunger whereby subsequent retraction of the plunger withdraws a needle on the needle holder into a shielded position within the body, the syringe being characterised in that the needle holder includes a radially extending flange adaoted to releasably engage with complementary engagement means within the body, the flange also surrounds and partially overlies an undercut recess in the needle holder, the connection means comprising a protuberance on the plunger which is adapted 15 to engage with a radially inner portion of the flange and to move it into the undercut recess on the needle holder :and thereby draw a radially outer portion of the flange radially inwardly free from the complementary engagement means. S 20
2. The syringe as defined in claim 1 wherein the body has a forward end, a rearward end, and a bore extending from the forward end to the rearward end, the needle holder being releasably retained on the body proximate the too. forward end and the plunger having an end mounted slidably iooo• within the bore of the body and extending out of the rearward end of the body.
3. The syringe as defined in claims i or 2 further including resilient braking means for retarding the retraction of the plunger, the resilient braking means being disposed within a space between the bore and the plunger, the resilient braking means either being disposed on the body and bearing on the plunger, or being disposed on the plunger and bearing on the body, to provide a braking force sufficient to retard but not stop the retraction of the plunger.
4. The syringe as defined in claim 3 in which the jA 1 braking means comprises a resilient cylindrical member oi :l 1 23 disposed within the body and having engagement members resiliently bearing against the plunger, the cylindrical member being removable longitudinally along the body between zones of different internal diameter to alter the braking force it applies to the plunger.
The syringe as defined in any one of the preceding claims further including stop means provided on the syringe body to prevent complete depression of the plunger into the body until after the syringe has been filled with an injectable liquid.
6. The syringe as defined in claim 5 wherein the stop means comprises an abutment formed on the body of the syringe engagable by engagement means on the plunger when the plunger is first depressed and which abutment means may be sheared from the body by subsequent retraction of the plunger.
7. A syringe as defined in any one of the preceding claims wherein the body includes a plurality of pivotable fingers within the bore proximate the one end of the body, 20 the plurality of pivotal fingers pivoting radially inward *,,tc so as to form an iris to substantially occlude the one end ":1X of the body when the needle on the needle holder is drawn into the body. T
8. The syringe as defined in any one of the preceeding claims whereiiL the needle is disposed on the needle holder *ir, at an angle to a longitudinal axis of the body. A syringe substantially as hereinbefore described with reference to Figures 5a to CO Vt DATED this 6th day of July 1994 ROBB PASCAL PATENT PTY LTD Patent Attorneys for the Applicant: F.B. RICE CO. l-- ABSTRACT A safety syringe for preventing "needle stick" injury and/or reuse of the syringe. The syringe comprises a body, a plunger mounted within the body, connection means for connecting the plunger to a needle holder adapted in use to carry a needle at the end of an injection stroke of the plunger whereby subsequent retraction of the plunger withdraws the needle into a shielded position within the body. The syringe includes a braking means disposed between the body and the plunger to retard but not stop the withdrawal of the plunger and needle after the injection stroke. The needle holder includes a radially extending flange which engages with a complementary rib or groove on the syringe until the needle holder is engaged by a protuberance on the plunger. Engagement of the protuberance with the needle holder serves to deform the needle holder and to draw the flange radially inwardly out I: of contact with the complimentary rib or groove on the syringe thereby allowing the needle holder and any needle attached to it to be drawn into the body of the syringe. 4; L C 4. 4.,
AU27118/92A 1989-09-18 1992-10-16 Syringe Ceased AU655507B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU27118/92A AU655507B2 (en) 1989-09-18 1992-10-16 Syringe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ6435 1989-09-18
AU27118/92A AU655507B2 (en) 1989-09-18 1992-10-16 Syringe

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU64236/90A Division AU625527B2 (en) 1989-09-18 1990-09-17 Syringe

Publications (2)

Publication Number Publication Date
AU2711892A AU2711892A (en) 1992-12-10
AU655507B2 true AU655507B2 (en) 1994-12-22

Family

ID=3715481

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27118/92A Ceased AU655507B2 (en) 1989-09-18 1992-10-16 Syringe

Country Status (1)

Country Link
AU (1) AU655507B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU636115B2 (en) * 1988-08-26 1993-04-22 Medical Patent Ltd. An injection syringe needle

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU636115B2 (en) * 1988-08-26 1993-04-22 Medical Patent Ltd. An injection syringe needle

Also Published As

Publication number Publication date
AU2711892A (en) 1992-12-10

Similar Documents

Publication Publication Date Title
US5578015A (en) Safety syringe incorporating automatic needle holder release
US5215533A (en) Safety syringe incorporating vacuum retraction of the needle
US6926697B2 (en) Adaptor for converting a non-safety syringe into a safety syringe
US5458576A (en) Safety syringe with retracting needle
US5658257A (en) Syringe
US6221055B1 (en) Retractable dental syringe
US5000735A (en) Single use syringe
US4915692A (en) Non-reusable syringe
US5997512A (en) Retractable dental syringe
AU2009201764B2 (en) One-use retracting syringe with positive needle retention
US2688325A (en) Piston plug withdrawal limiting means for hypodermic syringe devices and the like
EP0351541A1 (en) Safety syringe and combination needle cannula and lock therefor
IL179652A (en) Injection device
JPH08276012A (en) Injector with safe needle shield
CA2225572C (en) Shieldable syringe assembly
US4986812A (en) Locking device preventing reuse of a disposable syringe
GB2243552A (en) Improvements in or relating to single-use syringes
US5062833A (en) Non-reusable disposable syringe and locking device
US4878899A (en) Disposable syringe for one-time use
JP2951508B2 (en) Syringe
AU655507B2 (en) Syringe
US4909795A (en) Non-reusable syringe
NZ248919A (en) Safety syringe: plunger pulls needle holder into casing after use
AU660472B2 (en) A syringe
WO2001072363A1 (en) Retractable syringe

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired